REVIEW
Introduction
Liver function test (LFT) is a test that can easily be performed on the outpatient basis. Most of the patients with early-onset are first-time follow-up, for health screening and for follow-up during taking medication, regardless of their symptoms. Therefore, primary care physicians frequently encounter patients with abnormal liver function tests. It is very important to identify the cause, but it is not so easy to identify the cause in clinical practice. In particular, one of the most frequently encountered problems in primary care settings and health screening centers is the rise in Gamma Glutamyl Transpeptidase(y-GTP) levels. In general, liver function tests include aspartate [AMJ 2018; 11(2) : [83] [84] [85] [86] amino-transferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), Gamma Glutamyl Transpeptidase (y-GTP), bilirubin, total protein and albumin. During the liver function test, AST, ALT and ALP reflect liver damage, albumin and prothrombin time (PT) show production capacity of liver, and bilirubin represents the excretion ability of liver.
1 Therefore, in patients with mild liver function abnormalities, it is important to confirm the detailed history and to exclude common diseases causing abnormal liver function. In this case, follow-up observation may be necessary (Table 1) . 1. Structure and function y-GTP is a glycoprotein enzyme that catalyzes the transfer of gamma-glutamyl of gamma-glutamyl peptides to other peptides and I-amino acids, and is involved in amino acid reabsorption, transport, and hydrolysis of glutathione. 4 It is present in the canalicular membrane and biliary epithelial cells, part of the plasma membrane of hepatocytes. It also exists in other tissues such as the kidney, heart, pancreas, brain, and large intestine. The activity of y-GTP in the kidney is very active and is the most abundant in the brush border membrane in the tissue distribution. In the liver and pancreas, activity is low. 5 However, it does not exist in the bone or placenta.
The biochemical, structural, and immunological knowledge of y-GTP has been extensively studied. However, the relationship between the test method and each disease and isoenzyme is still controversial. 6 Therefore; the measurement of y-GTP is used as a very sensitive index for screening for the presence of liver dysfunction. It is used for the screening and diagnosis of intrahepatic and extrahepatic cholestasis or liver disease.
Clinical interpretation
y-GTP is present in hepatocyte and biliary epithelial cells and is a sensitive index for the presence of hepatocellular carcinoma, but its clinical usefulness is low because it is nonspecific. According to Table 2 , y-GTP elevation can be observed in diseases such as pancreatic disease, myocardial infarction, renal failure, chronic obstructive pulmonary disease, diabetes, and alcohol abuse. y-GTP may be elevated when taking warfarin or phenytoin, carbarmazepine, barbiturate, or other anticonvulsants, and it should be excluded through history taking. 7, 8 y-GTP is useful for the identification of alcohol consumption, suggesting alcoholic liver disease when the AST/ ALT ratio is 2 or more, together with the increase of y-GTP and aminotransferase. The sensitivity of y-GTP to alcohol abuse patients is known to range from 52 per cent to 94 per cent. However, y-GTP alone is limited in the diagnosis of alcohol abuse. Therefore, patients with y-GTP elevation should be considered together with other liver function items. 1, [9] [10] [11] [12] In general, the normal range of y-GTP is somewhat different according to the literature, but broadly, it has a normal range of 2~65IU/L. According to one study, y-GTP increases as age increases in men, decreases after age 55, and increases as age increases in women. 13 The elevated levels of aminotransferase in liver function tests are different from those in which ALP or y-GTP is elevated alone. Elevated rates of AST or AST/ALT can be considered as initial damage findings by alcohol. In acute or chronic hepatitis, y-GTP is moderately elevated to less than 5-fold the normal level. 14 One study showed that y-GTP is not useful compared to aminotransferase in acute hepatitis but it is highly valuable in subacute or chronic hepatitis. In particular, y-GTP is elevated in recovery phase. In acute hepatitis, y-GTP is used to evaluate the progression of acute hepatitis and as a good indicator of progression to chronic hepatitis. 15 Early diagnosis is needed because ALP and y-GTP increase several times compared with normal values after a few days after bile duct obstruction or intrahepatic cholestasis. It is known that y-GTP increases in about 90 per cent of patients with cholestasis. 16 In some cases, it is helpful to measure y-GTP when ALP is elevated in patients without symptoms. The reason for this is that, in the case of liver disease, y-GTP is also increased proportionally as ALP increases. However, if ALP is elevated but normal y-GTP, then bone disease should be suspected. 17 Therefore, y-GTP is a highly useful test that distinguishes whether the cause is liver disease or other diseases when ALP is elevated.
For another purpose, clinically, y-GTP is known to be the most affected by alcohol consumption. Therefore, the measurement of y-GTP is very helpful in diagnosing alcohol abuse. In chronic alcohol-intoxicated cases, all other liver function tests other than y-GTP are normal, so y-GTP is the most sensitive test for severe alcohol abuse. If you regularly take 60-80grams (more than 4 cups) of alcohol a day, you will have abnormal levels. Some surveys showed that even a low level such as 45grams (3 cups or more) makes it abnormal. 18 However, when the amount is lowered, it may
show normal values. In addition, when the AST: ALT ratio is at least 2:1 and y-GTP is twice the normal range, it strongly suggests alcohol abuse. Therefore, y-GTP can be a very useful indicator for follow-up management of alcohol. Generally, y-GTP is high in addicted drinkers. In particular, alcohol abusers who did not admit that they drank alcohol had a relatively high sensitivity (52-94 per cent) when they performed the test. 19 The sensitivity was relatively high but the specificity was low so It is preferable to conduct the inspection in parallel. The elevation of y-GTP in alcohol abusers is thought to be mainly due to enzyme induction, although it may be due to liver cell damage or cholestasis. When the drinking history exceeds 10 years, the increase of y-GTP is higher than the increase of ALP. While stopping drinking alcohol, y-GTP will be reduced in half after 26 days along with a relatively long half-life of alcohol. Thus, if y-GTP levels decrease after about 3 weeks, the increase in y-GTP may be attributed to alcohol consumption. In addition, if y-GTP is measured again after a certain period of time, it indicates that drinking is resumed. Therefore, it is used as an important index for observing well-being without alcohol consumption. However, the increase in y-GTP does not mean alcoholic hepatitis or fatty liver disease itself, but only chronic drinking. y-GTP can be used to detect alcohol abusers, but 1/3 of them may show normal findings. Generally, it is known that alcohol-induced fatty liver does not occur in <20g/day in women and <30g/day in men. In addition, MCV, AST, AST/ ALT ratio, and mitochondrial AST are other methods to evaluate alcohol intake, but the clinical usefulness is low because of low sensitivity and specificity. 20 Even in neonates, y-GTP is useful for diagnosis of bile duct injury or cholestasis. Atresia may be suspected but not characteristic when the y-GTP is elevated above 300IU/L in newborn infants. 21 In 80 per cent of diabetic patients with fatty liver, liver function or y-GTP findings are abnormal. In the present study, y-GTP levels were significantly correlated with the degree of fatty liver, suggesting that y-GTP is a useful predictor of body fat mass. 22 And y-GTP is an important predictor of obesity and fatty liver diagnosis because obesity increases and y-GTP level increases. It has been reported that y-GTP increases more than twice as the body mass index increases in men compared to women 23 and serum triglycerides have an important effect on y-GTP. 24 One study showed that y-GTP increased by 15 per cent in oral contraceptive use and decreased by 25 per cent in pregnant women and increased by 7 per cent after menopause. 25 If you are, you may be suspected of drug abuse. Taking drugs such as phenytoin, which induces microsomal enzymes, leads to y-GTP elevation. Aromatic drugs like Phenobarbital or phenytoin have characteristic findings of two-fold increase in the normal level of y-GTP. 26 If y-GTP increases above 500IU/L with ALP, malignant tumors should be suspected. There is also a report that a member of a family has a high elevation of y-GTP. Isoenzymes showed high levels of GGT-2, autosomal dominant inheritance, and high levels of y-GTP did not necessarily indicate liver or biliary disease. 27 There are reports that y-GTP is associated with stroke and early-onset morbidity at the middle age.
